EDGE study in Russian Federation: efficacy and safety of vildagliptine in comparison with other oral antidiabetic agents in patients with type 2 diabetes mellitus
According to international consensus, metformin is acknowledged as a first-line therapeutic agent for type 2 diabetes mellitus (T2DM). However, in most cases this treatment eventually requires intensification by supplementation with other hypoglycemic medications. The aim of the EDGE study (Effectiv...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN RU |
| Publié: |
Endocrinology Research Centre
2013
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/05a818a1512f45d2a2c1afbc3ea75738 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|